secwatch.observer — SEC 8-K summary
======================================

Issuer:     PetVivo Holdings, Inc. (PETV)
CIK:        0001512922
Form:       8-K
Filed at:   2026-09-22T11:00:29+00:00
Accession:  0001493152-26-043641
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetVivo board member Joseph Jasper resigns; Michael Handley appointed director
------------------------------------------------------------------------------

- Joseph Jasper resigned from PetVivo board effective Sept 22, 2026; no disagreement cited.
- Michael K. Handley appointed to fill vacancy; board remains six directors.
- Handley brings 25+ yrs life sciences; raised $700M+, 80 product launches, $4B transactions.
- Handley most recently CEO of Valion Bio; previously CEO/Chairman of Statera Biopharma.
- Handley to serve as non-employee director; compensation per existing program, prorated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512922/000149315226043641/0001493152-26-043641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512922/000149315226043641/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer